InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Leverone Jason A.. Director active across 1 company, notably OnKure Therapeutics, Inc.. Aggregated, 6 filings have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €7k. History available since 4 April 2025. The latest transaction was disclosed on 23 March 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Leverone Jason A. is a declarant linked to OnKure Therapeutics, Inc. on XNAS, where the listed role is Chief Financial Officer. Across 5 filings in total, the 5 sampled recent filings run from 2024-10-08 to 2026-03-24 and concern only sales, with total sell volume of EUR 6229 and no buys reported.